A Multicenter, Randomized, Open-label Trial of MERREM I.V. (meropenem, ICI 194,660) and PRIMAXIN I.V. (imipenem/cilastatin) for the Treatment of Community-acquired Bacterial Pneumonia.

Study identifier:3591US/0022

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Multicenter, Randomized, Open-label Trial of MERREM I.V. (meropenem, ICI 194,660) and PRIMAXIN I.V. (imipenem/cilastatin) for the Treatment of Community-acquired Bacterial Pneumonia.

Medical condition

infectious diseases

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 May 1998
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria